Advanced Health Intelligence Stock Total Asset
AHIDelisted Stock | USD 3.98 0.18 4.74% |
Advanced Health Intelligence fundamentals help investors to digest information that contributes to Advanced Health's financial success or failures. It also enables traders to predict the movement of Advanced Stock. The fundamental analysis module provides a way to measure Advanced Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Advanced Health stock.
Advanced |
Advanced Health Intelligence Company Total Asset Analysis
Advanced Health's Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Advanced Health Total Asset | 10.66 M |
Most of Advanced Health's fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Advanced Health Intelligence is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Advanced Health Intelligence has a Total Asset of 10.66 M. This is 99.98% lower than that of the Software sector and significantly higher than that of the Information Technology industry. The total asset for all United States stocks is 99.96% higher than that of the company.
Advanced Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Advanced Health's direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Advanced Health could also be used in its relative valuation, which is a method of valuing Advanced Health by comparing valuation metrics of similar companies.Advanced Health is currently under evaluation in total asset category among its peers.
Advanced Fundamentals
Return On Equity | -2.42 | |||
Return On Asset | -0.66 | |||
Operating Margin | (40.53) % | |||
Current Valuation | 12.9 M | |||
Shares Outstanding | 7.78 M | |||
Number Of Shares Shorted | 23.52 K | |||
Price To Book | 8.80 X | |||
Price To Sales | 20.01 X | |||
Revenue | 271.01 K | |||
Gross Profit | (5.77 M) | |||
EBITDA | (18.56 M) | |||
Net Income | (20.08 M) | |||
Cash And Equivalents | 6.01 M | |||
Cash Per Share | 0.25 X | |||
Total Debt | 1.16 M | |||
Debt To Equity | 0.19 % | |||
Current Ratio | 3.40 X | |||
Book Value Per Share | 0.01 X | |||
Cash Flow From Operations | (9.86 M) | |||
Short Ratio | 2.83 X | |||
Earnings Per Share | (0.32) X | |||
Target Price | 12.0 | |||
Number Of Employees | 12 | |||
Beta | 1.44 | |||
Market Capitalization | 13.11 M | |||
Total Asset | 10.66 M | |||
Retained Earnings | (62.61 M) | |||
Working Capital | (2.78 M) | |||
Z Score | -7.48 | |||
Net Asset | 10.66 M |
About Advanced Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Advanced Health Intelligence's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Advanced Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Advanced Health Intelligence based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Advanced Stock
If you are still planning to invest in Advanced Health Inte check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Advanced Health's history and understand the potential risks before investing.
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |